http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-071706-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 |
| filingDate | 2009-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8da2ddba980eb8671f47fec152d001f4 |
| publicationDate | 2010-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-071706-A1 |
| titleOfInvention | A PHARMACEUTICAL FORMULATION OF CILOSTAZOL SOLIDA OF SUSTAINED LIBERATION AND METHOD OF PREPARATION. |
| abstract | This refers to a solid sustained release pharmaceutical formulation comprising (a) an active medical ingredient, (b) a pregelatinized starch in an amount of 10 to 90% by weight based on the total weight of the formulation and (c) One or more types of enteric ingredients. Claim 2: The solid pharmaceutical formulation according to claim 1, characterized in that the active medical ingredient is a poorly soluble medicine. Claim 3: The solid pharmaceutical formulation according to claim 1, characterized in that the active medical ingredient is cilostazol. Claim 4: The solid pharmaceutical formulation according to any one of claims 1 to 3, characterized in that the one or more types of enteric ingredients comprise hydroxypropylmethylcellulose acetate succinate, hydroxypropylmethylcellulose phthalate, carboxymethyl ethyl cellulose, methacrylic acid copolymer L and / or copolymer of methacrylic acid S. Claim 13: The solid pharmaceutical formulation according to claim 11 or 12, characterized in that the organic acid is citric acid. Claim 18: The solid pharmaceutical formulation according to any one of claims 1 to 17 which is in the form of a particle. Claim 19: The solid pharmaceutical formulation according to any one of claims 1 to 17 which is in the form of a granule or a powder. |
| priorityDate | 2008-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.